FPH 2.91% $25.65 fisher & paykel healthcare corporation limited ord shares

Ann: RELINT: FPH: Disclosure of Directors and Officers Relevant...

  1. lightbulb Created with Sketch. 2
    • Release Date: 03/09/14 12:55
    • Summary: RELINT: FPH: Disclosure of Directors and Officers Relevant Interests
    • Price Sensitive: No
    • Download Document  9.71KB
    					FPH
    03/09/2014 12:55
    RELINT
    
    REL: 1255 HRS Fisher & Paykel Healthcare Corporation Limited
    
    RELINT: FPH: Disclosure of Directors and Officers Relevant Interests
    
    A Details of director or officer
    Name of director or officer of public issuer:  Deborah Anne BAILEY
    Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
    Name of related body corporate (if applicable):  Not Applicable
    Position held in public issuer:  Vice President Human Resources
    
    B Securities in public issuer or any related body corporate in which director
    or officer has relevant interest
    Number, class, and type of securities  "i) 21,000 options to acquire ordinary
    shares
    ii) 8,000 Performance Share Rights"
    
    C Nature of relevant interest and name of registered holder
    Nature of relevant interest in securities  Beneficial Ownership
    Name of registered holder of securities   Deborah Anne BAILEY
    
    D Details of acquisitions and disposals
    If the relevant interest was acquired--
    Date of acquisition  28 August 2014
    Consideration paid from acquisition  NZ$Nil
    
    If the relevant interest was disposed of--
    Date of disposal  Not applicable
    Consideration paid for disposal  Not applicable
    
    Type of transaction
    Describe the arrangement pursuant to which, or the circumstances in which,
    the acquisition took place  "i) Issue of 21,000 options to acquire ordinary
    shares
    ii) Issue of 8,000 Performance Share Rights"
    
    E Total number of transactions this notice relates to  Two
    
    F Date of last disclosure notice (whether in form 1 or form 2) by the
    director or officer  20 June 2014
    
    A Details of director or officer
    Name of director or officer of public issuer:  Lewis George GRADON
    Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
    Name of related body corporate (if applicable):  Not Applicable
    Position held in public issuer:  Senior VP Products & Technology
    
    B Securities in public issuer or any related body corporate in which director
    or officer has relevant interest
    Number, class, and type of securities  "i) 80,000  options to acquire
    ordinary shares
    ii) 30,000 Performance Share Rights"
    
    C Nature of relevant interest and name of registered holder
    Nature of relevant interest in securities  Beneficial Ownership
    Name of registered holder of securities  Lewis George GRADON
    
    D Details of acquisitions and disposals
    If the relevant interest was acquired--
    Date of acquisition  28 August 2014
    Consideration paid for acquisition  NZ$Nil
    
    If the relevant interest was disposed of--
    Date of disposal  Not Applicable
    Consideration paid for disposal  Not Applicable
    
    Type of transaction
    Describe the arrangement pursuant to which, or the circumstances in which,
    the acquisition took place  "i) Issue of 80,000 options to acquire ordinary
    shares
    ii) Issue of 30,000 Performance Share Rights"
    
    E Total number of transactions this notice relates to  Two
    
    F Date of last disclosure notice (whether in form 1 or form 2) by the
    director or officer  25 June 2014
    
    A Details of director or officer
    Name of director or officer of public issuer:  Paul ANDREASSI
    Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
    Name of related body corporate (if applicable):  Not Applicable
    Position held in public issuer:  Vice President Quality & Regulatory
    
    B Securities in public issuer or related body corporate to which this
    disclosure relates
    Number, class, and type of securities:   "i) 32,000 options to acquire
    ordinary shares
    ii) 12,000 Performance Share Rights"
    
    C Nature of relevant interest and name of registered holder
    Nature of relevant interest in securities:   Beneficial interest
    
    Name of registered holder of securities   Paul ANDREASSI
    
    D Details of acquisitions and disposals
    If the relevant interest was acquired--
    Date of acquisition:  28 August 2014
    Consideration paid for acquisition: NZ$Nil
    
    If the relevant interest was disposed of--
    Date of disposal:   Not Applicable
    Consideration paid for disposal:   Not Applicable
    
    Type of transaction
    Describe the arrangement pursuant to which, or the circumstances in which,
    the acquisition took place:   "i) Issue of 32,000 options to acquire ordinary
    shares
    ii) Issue of 12,000 Performance Share Rights"
    
    E Total number of transactions this notice relates to:  Two
    
    F Date of last disclosure notice (whether in form 1 or form 2) by the
    director or officer:   4 August 2014
    
    A Details of director or officer
    Name of director or officer of public issuer:  Paul Nigel SHEARER
    Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
    Name of related body corporate (if applicable):  Not Applicable
    Position held in public issuer:  Senior VP Sales & Marketing
    
    B Securities in public issuer or any related body corporate in which director
    or officer has relevant interest
    Number, class, and type of securities  "i) 80,000 options to acquire ordinary
    shares
    ii) 30,000 Performance Share Rights"
    
    C Nature of relevant interest and name of registered holder
    Nature of relevant interest in securities  Beneficial Ownership
    Name of registered holder of securities  Paul Nigel SHEARER
    
    D Details of acquisitions and disposals
    If the relevant interest was acquired--
    Date of acquisition  28 August 2014
    Consideration paid from acquisition  NZ$Nil
    
    If the relevant interest was disposed of--
    Date of disposal  Not Applicable
    Consideration received from disposal  Not Applicable
    
    Type of transaction
    Describe the arrangement pursuant to which, or the circumstances in which,
    the acquisition took place  "i) Issue of 80,000 options to acquire ordinary
    shares
    ii) Issue of 30,000 Performance Share Rights"
    
    E Total number of transactions this notice relates to  Two
    
    F Date of last disclosure notice (whether in form 1 or form 2) by the
    director or officer  20 June 2014
    
    A Details of director or officer
    Name of director or officer of public issuer:  Antony George BARCLAY
    Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
    Name of related body corporate (if applicable):  Not Applicable
    Position held in public issuer:  Chief Financial Officer & Company Secretary
    
    B Securities in public issuer or related body corporate to which this
    disclosure relates
    Number, class, and type of securities:   "i) 52,000 options to acquire
    ordinary shares
    ii) 20,000 Performance Share Rights"
    
    C Nature of relevant interest and name of registered holder
    Nature of relevant interest in securities:   Beneficial Ownership
    Name of registered holder of securities   Antony George BARCLAY
    
    D Details of acquisitions and disposals
    If the relevant interest was acquired--
    Date of acquisition:   28 August 2014
    Consideration paid for acquisition:  NZ$Nil
    
    If the relevant interest was disposed of--
    Date of disposal   Not applicable
    Consideration paid for disposal   Not applicable
    
    Type of transaction
    Describe the arrangement pursuant to which, or the circumstances in which,
    the acquisition took place:   "i) Issue of 52,000 options to acquire ordinary
    shares
    ii) Issue of 20,000 Performance Share Rights"
    
    E Total number of transactions this notice relates to:  Two
    
    F Date of last disclosure notice (whether in form 1 or form 2) by the
    director or officer:   3 September 2014
    
    A Details of director or officer
    Name of director or officer of public issuer:  Winston FONG
    Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
    Name of related body corporate (if applicable):  Not Applicable
    Position held in public issuer:  Vice President ICT
    
    B Securities in public issuer or related body corporate to which this
    disclosure relates
    Number, class, and type of securities:   "i) 23,000 options to acquire
    ordinary shares
    ii) 9,000 Performance Share Rights"
    
    C Nature of relevant interest and name of registered holder
    Nature of relevant interest in securities:   Beneficial Ownership
    Name of registered holder of securities   Winston FONG
    
    D Details of acquisitions and disposals
    If the relevant interest was acquired--
    Date of acquisition:   28 August 2014
    Consideration paid for acquisition:   NZ$Nil
    
    If the relevant interest was disposed of--
    Date of disposal:   Not Applicable
    Consideration paid for disposal:   Not Applicable
    
    Type of transaction
    Describe the arrangement pursuant to which, or the circumstances in which,
    the acquisition took place:   "i) Issue of 23,000 options to acquire ordinary
    shares
    ii) Issue of 9,000 Performance Share Rights"
    
    E Total number of transactions this notice relates to:  Two
    
    F Date of last disclosure notice (whether in form 1 or form 2) by the
    director or officer:   11 July 2014
    
    A Details of director or officer
    Name of director or officer of public issuer:  Michael Grenfell DANIELL
    Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
    Name of related body corporate (if applicable):  Not Applicable
    Position held in public issuer:  Managing Director/Chief Executive Officer
    
    B Securities in public issuer or any related body corporate in which director
    or officer has relevant interest
    Number, class, and type of securities:   Ordinary shares and options to
    acquire ordinary shares
    
    C Nature of relevant interest and name of registered holder
    Nature of relevant interest in securities:   Beneficial Ownership
    Name of registered holder of securities   Michael Grenfell DANIELL
    
    D Details of acquisitions and disposals
    If the relevant interest was acquired--
    Date of acquisition   4 June 2014
    Consideration paid for acquisition   $Nil
    
    If the relevant interest was disposed of--
    Date of cancellation: 4 June 2014
    Consideration received for cancellation:   $Nil
    
    Type of transaction
    Describe the arrangement pursuant to which, or the circumstances in which,
    the acqusition or disposal took place:  Cancellation of 160,000 FPH options
    and issue of 24,320 ordinary shares
    
    E Total number of transactions this notice relates to:  One
    
    F Date of last disclosure notice (whether in form 1 or form 2) by the
    director or officer:   20 December 2013
    End CA:00254811 For:FPH    Type:RELINT     Time:2014-09-03 12:55:06
    				
 
watchlist Created with Sketch. Add FPH (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.